Cargando…
Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures
Cancer is the leading cause of death worldwide. Cancer immunotherapy involves reinvigorating the patient’s own immune system to fight against cancer. While novel approaches like Chimeric Antigen Receptor (CAR) T cells, bispecific T cell engagers, and immune checkpoint inhibitors have shown promising...
Autores principales: | Shah, Deep, Soper, Brian, Shopland, Lindsay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248525/ https://www.ncbi.nlm.nih.gov/pubmed/37304291 http://dx.doi.org/10.3389/fimmu.2023.1190379 |
Ejemplares similares
-
Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives
por: Atallah-Yunes, Suheil Albert, et al.
Publicado: (2022) -
Editorial: Understanding the Cytokine Release Syndrome: Toward Improving Cancer Immunotherapy
por: Martín-Antonio, Beatriz
Publicado: (2021) -
Editorial: Cytokine and cytokine receptor-based immunotherapies: Updates, controversies, challenges, and future perspectives
por: Wang, Jun, et al.
Publicado: (2022) -
Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
por: Shou, Jiawei, et al.
Publicado: (2022) -
Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions
por: Wurster, Sebastian, et al.
Publicado: (2022)